Voloridge Investment Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-465,445
| Closed | -$6.85M | – | 1135 |
|
|
2023
Q4 | $6.85M | Buy |
465,445
+196,478
| +73% | +$2.89M | 0.03% | 551 |
|
|
2023
Q3 | $4.92M | Buy |
268,967
+154,338
| +135% | +$2.83M | 0.02% | 665 |
|
|
2023
Q2 | $2.47M | Sell |
114,629
-20,836
| -15% | -$449K | 0.01% | 926 |
|
|
2023
Q1 | $3.97M | Sell |
135,465
-159,802
| -54% | -$4.69M | 0.02% | 753 |
|
|
2022
Q4 | $10.9M | Sell |
295,267
-86,945
| -23% | -$3.21M | 0.06% | 407 |
|
|
2022
Q3 | $10.8M | Buy |
+382,212
| New | +$10.8M | 0.06% | 421 |
|